Dedicated 75-min ERA - European Renal Association late-breaking session on the FLOW trial on May 24 featuring: - Baseline data Richard Pratley MD - Key findings Vlado Perkovic - Safety data #JohannesMann - Summary & clinical implications Katherine Tuttle - Independent commentary Christoph Wanner #ERA24

Amazing study from thomas robert ! People, please stop using/eating/applying potential toxic products…

Now open access in J Autoimmun Balancing efficacy and safety of complement inhibitors sciencedirect.com/science/articl…

CJASN Thanks, but how about those pts treated with SGLT2i that do not have anaemia upfront??? 🧐Beware of SGLT2i-induced erythrocytosis, which was never reported in any of the RCTs but occurs in clinical practice ⏩ajkd.org/article/S0272-…

Introduire une gliflozine à moins de 20 ml/mn de dfg paraît une bonne idée pour retarder la mise en dialyse. pubmed.ncbi.nlm.nih.gov/38684099/

🙏🏽Honored to join KDIGO ‘Controversies Conference on #APOL1 #KidneyDiseases’ ★Ghana🇬🇭, Africa🌍 🎤Stimulating dialogue to help guide #KDIGO & 🌏on therapeutic management➕future research in APOL1 kidney diseases🧬| 🙌🏾nichole jefferson | Gbadegesin Lab | abdou niang | Kirk Campbell🤝🏽

Chronic kidney disease is an evolving global health emergency- now the major non communicable disease Important figures below 👇🏼

Aux membres de la SFNDT Je suis honoré par le soutien de la société pour ma candidature au Council de ERA - European Renal Association J'espère le soutien des néphrologues mmbres de la SFNDT, donc de l'ERA! Votez maintenant sur le site : lnkd.in/ekTipBAR ou au congrès #Stockholm #ERA24 🙏

Prominent line-up for the presentation of the FLOW trial in a dedicated session at ERA - European Renal Association 2024 in Stockholm

Third NEJM simultaneous publication at #ERA24 bravo Tobias B. Huber and team!! Autoantibodies targeting nephrin in podocytopathies nejm.org/doi/full/10.10…

Happy to read in @JASNnews that kidney fibrosis is finally recognized as a "consequence" and no longer a cause for CKD, like we were told for 30Y, despite absence of evidence for causation... (show me eGFR data when blocking fibrosis) Associations can produce a lot of confusion

I am sharing a 50-day free access link to our paper “Erythrocytosis and CKD” published in AJKD. For those who would like to save a copy. Hans-Joachim Anders Michel Jadoul authors.elsevier.com/a/1jD-Xz-QWLWFr

The role of complement in kidney disease: conclusions from KDIGO Jonathan Barratt Katalin Susztak Wolfgang C. Winkelmayer Michel Jadoul Laurence H Beck, Jr #Nephpearls 👉pubmed.ncbi.nlm.nih.gov/38844295/

A systematic review of 57 studies of ~29,000 physicians in 25 countries found nearly 1 in 5 physicians experienced PTSD during Covid jamanetwork.com/journals/jaman…

Hamburg news: Editorial with highly elaborated schematic artwork on Antinephrin Antibodies. Jochen Reiser MD PhD Julie R Ingelfinger International Society of Glomerular Disease Deutsche Gesellschaft für Nephrologie (DGfN) e.V. ERA - European Renal Association American Society of Nephrology HCKH_Hamburg Universität Hamburg UKE Hamburg

Nephrology, Dialysis and Transplantation (NDT) is preparing an exciting review series on kidney biology. After contributions on phosphate, iron and uromodulin biology, Jana Kröse in my team wrote an excellent overview on Magnesium Biology! ➡️ academic.oup.com/ndt/advance-ar…

The ISN community mourns the passing of Dr. Barry M. Brenner, a visionary leader in nephrology. As a co-chair of ISN's Commission for the Global Advancement of Nephrology (COMGAN), Dr. Brenner played a pivotal role in expanding nephrology education and training worldwide. His

Explaining International Trends in Mortality on Hemodialysis Through Changes in Hemodialysis Practices in DOPPS buff.ly/4cE9rO2 Michel Jadoul Bruce Robinson Arbor Research University of Michigan - Division of Nephrology Michigan Public Health

Metabolic Alkalosis Treatment Standard doi.org/10.1093/ndt/gf…